Impacto económico de las exacerbaciones agudas en EPOC desde la perspectiva del SNS español
Autores:
Cost-effectiveness analysis of indacaterol / glycopirronium (QVA149) fixed combination as a maintenance bronchodilator treatment in adult patients with chronic obstructive pulmonary disease in Spain
The influence of improved adherence and persistence in chronic obstructive pulmonary disease (COPD) costs: systematic review of the literature
Adherencia, persistencia en el tratamiento y costes de la enfermedad pulmonar obstructiva crónica (EPOC) en el ámbito sanitario público: revisión de la literatura
Optimizing chronic obstructive pulmonary disease (COPD) diagnosis and management to reduce healthcare costs: systematic review and modeling
The impact of asthma severity on the total cost of asthma patients in the Valencia region
